These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 2981083

  • 1. Increased adrenocorticotropin, cortisol, and arginine vasopressin secretion in primates after the antiglucocorticoid steroid RU 486: dose response relationships.
    Healy DL, Chrousos GP, Schulte HM, Gold PW, Hodgen GD.
    J Clin Endocrinol Metab; 1985 Jan; 60(1):1-4. PubMed ID: 2981083
    [Abstract] [Full Text] [Related]

  • 2. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L, Chrousos GP, Loriaux DL, Barnes K, Munson P, Nieman L, Schaison G.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [Abstract] [Full Text] [Related]

  • 3. The new steroid analog RU 486 inhibits glucocorticoid action in man.
    Bertagna X, Bertagna C, Luton JP, Husson JM, Girard F.
    J Clin Endocrinol Metab; 1984 Jul; 59(1):25-8. PubMed ID: 6327758
    [Abstract] [Full Text] [Related]

  • 4. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X, Escourolle H, Pinquier JL, Coste J, Raux-Demay MC, Perles P, Silvestre L, Luton JP, Strauch G.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [Abstract] [Full Text] [Related]

  • 5. Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man.
    Hensen J, Hader O, Bähr V, Oelkers W.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):668-71. PubMed ID: 2831245
    [Abstract] [Full Text] [Related]

  • 6. The effect of acute exercise on the secretion of corticotropin-releasing factor, arginine vasopressin, and adrenocorticotropin as measured in pituitary venous blood from the horse.
    Alexander SL, Irvine CH, Ellis MJ, Donald RA.
    Endocrinology; 1991 Jan; 128(1):65-72. PubMed ID: 1846116
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL, Irvine CH, Livesey JH, Donald RA.
    Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Corticotropin-releasing factor alone, but not arginine vasopressin alone, stimulates the release of adrenocorticotropin in the conscious intact sheep.
    McFarlane A, Coghlan J, Tresham J, Wintour EM.
    Endocrinology; 1995 May; 136(5):1821-7. PubMed ID: 7720626
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of the ACTH response to human CRH by pretreatment with the antiglucocorticoid RU-486.
    Hermus AR, Pieters GF, Pesman GJ, Smals AG, Benraad TJ, Kloppenborg PW.
    Eur J Clin Pharmacol; 1987 May; 31(5):609-11. PubMed ID: 3030764
    [Abstract] [Full Text] [Related]

  • 12. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man.
    Rittmaster RS, Cutler GB, Gold PW, Brandon DD, Tomai T, Loriaux DL, Chrousos GP.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):371-6. PubMed ID: 3025246
    [Abstract] [Full Text] [Related]

  • 13. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
    Alexander SL, Irvine CH.
    Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
    [Abstract] [Full Text] [Related]

  • 14. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA, Livesey JH, Florkowski C, Or HK, Donald RA, Espiner EA.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [Abstract] [Full Text] [Related]

  • 15. Adrenocorticotropin/cortisol and arginine-vasopressin secretory patterns in response to ghrelin in normal men.
    Coiro V, Saccani-Jotti G, Minelli R, Melani A, Milli B, Manfredi G, Volpi R, Chiodera P.
    Neuroendocrinology; 2005 Jan; 81(2):103-6. PubMed ID: 15860925
    [Abstract] [Full Text] [Related]

  • 16. Transient inhibition of RU 486 antiglucocorticoid action by dexamethasone.
    Raux-Demay MC, Pierret T, Bouvier d'Yvoire M, Bertagna X, Girard F.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):230-3. PubMed ID: 2152931
    [Abstract] [Full Text] [Related]

  • 17. The effects of cortisol, vasopressin (AVP), and corticotropin-releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte-stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse.
    Livesey JH, Donald RA, Irvine CH, Redekopp C, Alexander SL.
    Endocrinology; 1988 Aug; 123(2):713-20. PubMed ID: 2840266
    [Abstract] [Full Text] [Related]

  • 18. Effects of vasopressin antiserum on the response of adrenocorticotropin and cortisol to hemorrhage.
    Carlson DE, Gann DS.
    Endocrinology; 1984 Feb; 114(2):317-24. PubMed ID: 6317351
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.